Cargando…
miR-125a-5p suppresses colorectal cancer progression by targeting VEGFA
BACKGROUND: MiR-125a-5p has been reported to be involved in the development and progression of various cancers. However, the biological function and underlying mechanisms in colorectal cancer(CRC) still remain unclear. Here, we explored the potential biological roles of miR-125a-5p in CRC. METHODS:...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248379/ https://www.ncbi.nlm.nih.gov/pubmed/30510452 http://dx.doi.org/10.2147/CMAR.S161990 |
_version_ | 1783372622776500224 |
---|---|
author | Yang, Xuehua Qiu, Jianwei Kang, Haifeng Wang, Yaming Qian, Junbo |
author_facet | Yang, Xuehua Qiu, Jianwei Kang, Haifeng Wang, Yaming Qian, Junbo |
author_sort | Yang, Xuehua |
collection | PubMed |
description | BACKGROUND: MiR-125a-5p has been reported to be involved in the development and progression of various cancers. However, the biological function and underlying mechanisms in colorectal cancer(CRC) still remain unclear. Here, we explored the potential biological roles of miR-125a-5p in CRC. METHODS: The expression of miR-125a-5p was detected using quantitative real-time PCR (qRT-PCR), biological functions of miR-125a-5p were assessed by cell counting kit-8, wound-healing, transwell invasion, and human umbilical vein endothelial cell (HUVEC) tube formation assays in vitro and animal experiments in vivo. RESULTS: We found that miR-125a-5p was downregulated in CRC tissues and cell lines, it inhibited CRC cell proliferation, migration, and invasion and reduced the ability of HUVECs to form tubes. Moreover, we verifed that miR-125a-5p suppressed CRC growth and metastasis in vivo. Additionally, we showed that VEGFA, a direct target gene of miR-125a-5p, could reverse the inhibitory effect caused by miR-125a-5p overexpression. CONCLUSION: miR-125a-5p might serve as a tumor suppressor in CRC and could be regarded as a potential therapeutic candidate for CRC. |
format | Online Article Text |
id | pubmed-6248379 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-62483792018-12-03 miR-125a-5p suppresses colorectal cancer progression by targeting VEGFA Yang, Xuehua Qiu, Jianwei Kang, Haifeng Wang, Yaming Qian, Junbo Cancer Manag Res Original Research BACKGROUND: MiR-125a-5p has been reported to be involved in the development and progression of various cancers. However, the biological function and underlying mechanisms in colorectal cancer(CRC) still remain unclear. Here, we explored the potential biological roles of miR-125a-5p in CRC. METHODS: The expression of miR-125a-5p was detected using quantitative real-time PCR (qRT-PCR), biological functions of miR-125a-5p were assessed by cell counting kit-8, wound-healing, transwell invasion, and human umbilical vein endothelial cell (HUVEC) tube formation assays in vitro and animal experiments in vivo. RESULTS: We found that miR-125a-5p was downregulated in CRC tissues and cell lines, it inhibited CRC cell proliferation, migration, and invasion and reduced the ability of HUVECs to form tubes. Moreover, we verifed that miR-125a-5p suppressed CRC growth and metastasis in vivo. Additionally, we showed that VEGFA, a direct target gene of miR-125a-5p, could reverse the inhibitory effect caused by miR-125a-5p overexpression. CONCLUSION: miR-125a-5p might serve as a tumor suppressor in CRC and could be regarded as a potential therapeutic candidate for CRC. Dove Medical Press 2018-11-16 /pmc/articles/PMC6248379/ /pubmed/30510452 http://dx.doi.org/10.2147/CMAR.S161990 Text en © 2018 Yang et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Yang, Xuehua Qiu, Jianwei Kang, Haifeng Wang, Yaming Qian, Junbo miR-125a-5p suppresses colorectal cancer progression by targeting VEGFA |
title | miR-125a-5p suppresses colorectal cancer progression by targeting VEGFA |
title_full | miR-125a-5p suppresses colorectal cancer progression by targeting VEGFA |
title_fullStr | miR-125a-5p suppresses colorectal cancer progression by targeting VEGFA |
title_full_unstemmed | miR-125a-5p suppresses colorectal cancer progression by targeting VEGFA |
title_short | miR-125a-5p suppresses colorectal cancer progression by targeting VEGFA |
title_sort | mir-125a-5p suppresses colorectal cancer progression by targeting vegfa |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248379/ https://www.ncbi.nlm.nih.gov/pubmed/30510452 http://dx.doi.org/10.2147/CMAR.S161990 |
work_keys_str_mv | AT yangxuehua mir125a5psuppressescolorectalcancerprogressionbytargetingvegfa AT qiujianwei mir125a5psuppressescolorectalcancerprogressionbytargetingvegfa AT kanghaifeng mir125a5psuppressescolorectalcancerprogressionbytargetingvegfa AT wangyaming mir125a5psuppressescolorectalcancerprogressionbytargetingvegfa AT qianjunbo mir125a5psuppressescolorectalcancerprogressionbytargetingvegfa |